These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 29694420
1. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation. Garnier AS, Duveau A, Demiselle J, Croué A, Subra JF, Sayegh J, Augusto JF. PLoS One; 2018; 13(4):e0196101. PubMed ID: 29694420 [Abstract] [Full Text] [Related]
2. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy. Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS. Transplant Proc; 2017 Apr; 49(3):541-545. PubMed ID: 28340830 [Abstract] [Full Text] [Related]
3. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F. Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544 [Abstract] [Full Text] [Related]
4. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation. Berthoux F, Suzuki H, Mohey H, Maillard N, Mariat C, Novak J, Julian BA. J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003 [Abstract] [Full Text] [Related]
5. A proliferation-inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients. Martín-Penagos L, Benito-Hernández A, San Segundo D, Sango C, Azueta A, Gómez-Román J, Fernández-Fresnedo G, López-Hoyos M, Ruiz JC, Rodrigo E. Clin Transplant; 2019 Apr; 33(4):e13502. PubMed ID: 30776158 [Abstract] [Full Text] [Related]
6. Favorable outcome of renal transplantation in patients with IgA nephropathy. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657 [Abstract] [Full Text] [Related]
7. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Clin Transplant; 2005 Oct; 19 Suppl 14():41-8. PubMed ID: 15955168 [Abstract] [Full Text] [Related]
8. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT. Lemes-Canuto AP, de Sandes-Freitas TV, Medina-Pestana JO, Mastroianni-Kirsztajn G. J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382 [Abstract] [Full Text] [Related]
9. IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. Coppo R, Amore A, Cirina P, Messina M, Basolo B, Segoloni G, Berthoux F, Boulharouz R, Egido J, Alcazar R. Nephrol Dial Transplant; 1995 Dec; 10(12):2310-5. PubMed ID: 8808231 [Abstract] [Full Text] [Related]
10. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients. Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N. Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446 [Abstract] [Full Text] [Related]
11. Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study. Jäger C, Stampf S, Molyneux K, Barratt J, Golshayan D, Hadaya K, Huynh-Do U, Binet FI, Mueller TF, Koller M, Kim MJ. BMC Nephrol; 2022 May 10; 23(1):178. PubMed ID: 35538438 [Abstract] [Full Text] [Related]
12. IgA nephropathy and kidney transplantation according to the Oxford classification. Vasconcelos AS, Mazzali M, de Sousa MV. J Bras Nefrol; 2023 May 10; 45(3):350-356. PubMed ID: 36626310 [Abstract] [Full Text] [Related]
13. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy. Bantis C, Heering PJ, Aker S, Schwandt C, Grabensee B, Ivens K. J Nephrol; 2008 May 10; 21(6):941-6. PubMed ID: 19034880 [Abstract] [Full Text] [Related]
14. Post-transplant immunoglobulin A deposition and nephropathy in allografts. Sofue T, Suzuki H, Ueda N, Kushida Y, Minamino T. Nephrology (Carlton); 2018 Jul 10; 23 Suppl 2():4-9. PubMed ID: 29968406 [Abstract] [Full Text] [Related]
15. Utility of Oxford Classification in Post-Transplant Immunoglobulin A Nephropathy. Agrawal V, Singh A, Kaul A, Verma R, Jain M, Pandey R. Transplant Proc; 2017 Dec 10; 49(10):2274-2279. PubMed ID: 29198660 [Abstract] [Full Text] [Related]
16. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents. Avasare RS, Rosenstiel PE, Zaky ZS, Tsapepas DS, Appel GB, Markowitz GS, Bomback AS, Canetta PA. Am J Nephrol; 2017 Dec 10; 45(2):99-106. PubMed ID: 28056461 [Abstract] [Full Text] [Related]
17. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database. Leeaphorn N, Garg N, Khankin EV, Cardarelli F, Pavlakis M. Transpl Int; 2018 Feb 10; 31(2):175-186. PubMed ID: 28926143 [Abstract] [Full Text] [Related]
18. Single-center long-term results of renal transplantation for IgA nephropathy. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Transplantation; 1998 Apr 27; 65(8):1053-60. PubMed ID: 9583865 [Abstract] [Full Text] [Related]
19. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P. Nephrol Dial Transplant; 2013 May 27; 28(5):1305-14. PubMed ID: 23229925 [Abstract] [Full Text] [Related]
20. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy. Ng YS, Vathsala A, Chew ST, Chiang GS, Woo KT. Med J Malaysia; 2007 Jun 27; 62(2):109-13. PubMed ID: 18705440 [Abstract] [Full Text] [Related] Page: [Next] [New Search]